Your browser doesn't support javascript.
loading
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization.
Nelson, Cody S; Jenks, Jennifer A; Pardi, Norbert; Goodwin, Matthew; Roark, Hunter; Edwards, Whitney; McLellan, Jason S; Pollara, Justin; Weissman, Drew; Permar, Sallie R.
Affiliation
  • Nelson CS; Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA cody.nelson@duke.edu.
  • Jenks JA; Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Pardi N; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Goodwin M; Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Roark H; Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Edwards W; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • McLellan JS; Department of Molecular Biosciences, University of Texas at Austin, Austin, Texas, USA.
  • Pollara J; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.
  • Weissman D; Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Permar SR; Human Vaccine Institute, Duke University Medical Center, Durham, North Carolina, USA.
J Virol ; 94(9)2020 04 16.
Article in En | MEDLINE | ID: mdl-32051265
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Envelope Proteins / Cytomegalovirus Vaccines / Cytomegalovirus Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Virol Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Viral Envelope Proteins / Cytomegalovirus Vaccines / Cytomegalovirus Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Virol Year: 2020 Type: Article Affiliation country: United States